Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yaniv Lustig and Victoria Indenbaum.
Yaniv Lustig
Connection Strength
1.620
Victoria Indenbaum
  1. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020; 15(11):e0241164.
    View in: PubMed
    Score: 0.915
  2. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
    View in: PubMed
    Score: 0.239
  3. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation. EClinicalMedicine. 2020 Dec; 29:100651.
    View in: PubMed
    Score: 0.229
  4. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021 Dec; 27(12):1851-1855.
    View in: PubMed
    Score: 0.060
  5. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
    View in: PubMed
    Score: 0.060
  6. A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel. Vaccines (Basel). 2021 Jun 08; 9(6).
    View in: PubMed
    Score: 0.059
  7. BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response. J Heart Lung Transplant. 2021 08; 40(8):759-762.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.